HCA

HCA Healthcare, Inc. NYQ · HCA

$371.18 -14.56 (-3.77%)

Pullback · -1.39σ

+ Compare Open in Sniper

Mkt cap $82.3B

P/E 12.8

Day $371.12 – $386.27

52wk $353.99 – $556.52

Avg vol 1.6M

Beta 1.13

Div yld 0.84%

Next earnings 2026-07-24

Quick read

Plain English

HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States.

HCA last traded at $371.18, down 3.8% on the day; that's in the lower part of its 52-week range ($353.99–$556.52). Right now it's dipped below its recent average — a spot where watchers often look for signs the dip is stabilizing.

The next scheduled earnings report (2026-07-24) is the biggest known catalyst on the calendar, and after the recent dip, watch whether the price stops making lower lows before assuming the worst is over.

A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.

Today's read

Grading desk →

KC1 lower, -1.44 ATR from EMA21 — no notable pattern

Long —

score 17 · tech 17 / 80 · support 0 / 20

KC1 lower, -1.44 ATR from EMA21 · no notable pattern

· KC1 lower stretch — light dip

How this grade was earned

total 17 pts

Cycle position 14

Market fit 3

Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.

Short —

score 12 · tech 12 / 80 · support 0 / 20

below KC1 upper, -1.44 ATR from EMA21 · no notable pattern

· Aligned with weak downtrend

How this grade was earned

total 12 pts

Cycle position 6

Market fit 6

Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.

132-Day Trend Zones

Full chart →

21 EMA +1 ATR +2 ATR −2 ATR

—

O — H — L — C —

— —

Valuation & accounting

Valuation desk →

Our cash-flow model pegs fair value near $215.00 (fair range $215–$1022); today's price sits 79% above that estimate. The model's verdict is “Overvalued” and accounting quality screens as Weak. Model estimates only — do your own due diligence.

Intrinsic (DCF)

$215.00

Fair-value range

$215.00 – $1022.36

Margin of safety

-79%

Verdict

Overvalued

Accounting quality Weak

✓ Gross margin 42% (pricing power)

⚠ Debt exceeds cash
⚠ Quick ratio 0.73 (fragile)
⚠ Negative retained earnings

Price implies ~10% growth (vs trailing rev yoy). Model estimate — do your own due diligence.

Key statistics

All statistics →

HCA is a $82.3 billion company, priced at 13× last year's earnings, and the stock is trading near the bottom of its 52-week range.

Mkt cap $82.3B

P/E ttm 12.8

Fwd P/E 11.3

Beta 1.13

Day range $371.12 – $386.27

52w range $353.99 – $556.52

Avg vol 1.6M

RSI(2) 27.6

ROE —

Net mgn 8.9%

FCF mgn 7.5%

Debt/Eq —

Div yld 0.84%

Sector Healthcare

Industry Medical Care Facilities

Next earn 2026-07-24

52-week range · today's price

$353.99$556.52

More on HCA

Options idea

See more →

CALL $375 2026-08-21

$17.81

PUT $380 2026-08-21

$21.90

Earnings

See more →

Last reported: 2026-04-24
EPS (act / est): 7.15 / 7.13
Surprise: +0.3%
Next report: 2026-07-24

About

HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician prac…